test

Karen Hager

@Blue Owl Capital Holdings Lp

Latest period2024 - Q3ReportedManaged Assets$518.429BTotal holdings137
Assets growth rate144084.03%Assets growth rate (2-Q avg)72027.93%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Blue Owl Capital Holdings Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 137 positions.

Assets under management

The assets under management (AUM) of Blue Owl Capital Holdings Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 518.429B in assets, with a quarterly growth rate of 144084.03% and a 2-quarter average growth rate of 72027.93%. The portfolio is managed by Karen Hager, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
LRMRLarimar Therapeutics Inc
Recent Activity
Increased 7.97%
5.27%
$27.293B
4.167M shares@ $6550.01 avg price
ENGNEngene Holdings Inc
Recent Activity
Increased 24.87%
3.9%
$20.189B
3.059M shares@ $6600.0 avg price
CNTXContext Therapeutics Inc
Recent Activity
Increased 4.85%
2.05%
$10.606B
5.411M shares@ $1960.0 avg price
AQSTAquestive Therapeutics Inc
Recent Activity
Increased 7.46%
1.18%
$6.1B
1.225M shares@ $4980.0 avg price
CMPXCompass Therapeutics Inc
Recent Activity
Increased 1.77%
1.03%
$5.299B
2.88M shares@ $1840.0 avg price
PYXSPyxis Oncology Inc
Recent Activity
Increased 7.65%
0.8%
$4.133B
1.126M shares@ $3670.01 avg price
JANXJanux Therapeutics Inc
Recent Activity
Increased 100%
0.71%
$3.634B
80,000 shares@ $45430.0 avg price
GPCRStructure Therapeutics Inc
Recent Activity
Increased 18.19%
0.56%
$2.853B
65,000 shares@ $43890.0 avg price
SYRSSyros Pharmaceuticals Inc
Recent Activity
Increased 51.35%
0.22%
$1.109B
515,855 shares@ $2150.0 avg price
ENGNWEngene Holdings Inc
Recent Activity
Increased 898.85%
0.15%
$728.427M
511,177 shares@ $1425.0 avg price